Recombinant Anti-CD3 x Anti-TPBG Bispecific Antibody (Diabody-CH3) (BSDBC-106)

Recombinant Anti-CD3 x Anti-TPBG Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-CD3 and anti-TPBG antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can retarget T cells to tumor cells. It is designed for the research of Renal cell cancer (RCC); Non-small lung cancer therapy.

Datasheet INQUIRY

Specifications

Targets

CD3 & TPBG

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Renal cell cancer (RCC); Non-small lung cancer

Targets

Target 1

CD3

Gene ID

916

UniProt ID

P07766

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Target 2

TPBG

Gene ID

7162

UniProt ID

Q13641

Alternative Names

5T4; M6P1; 5T4AG; WAIF1; trophoblast glycoprotein; TPBG

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-TPBG Bispecific Antibody (Diabody-CH3) (BSDBC-106). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD3 x Anti-TPBG Bispecific Antibody (Diabody-CH3) (CAT#: BSDBC-106)

Specifications

Targets

Customer Reviews and Q&As